Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temsirolimus + Cisplatin + Cetuximab in R/M SCCHN
NCT01015664Phase 2Terminated
- Sponsor
- University of Tennessee Cancer Institute
- Start
- Feb 2010
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temsirolimus in squamous cell carcinoma of the head and neck (HNSCC), sponsored by University of Tennessee Cancer Institute. Started Feb 2010; status: terminated.
02
Drugs
temsirolimus
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT01015664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01015664.